AFROCENTRIC INVESTMENT CORPORATION LIMITED - Dealings relating to vesting of shares under the AfroCentric LTIP

Dealings relating to vesting of shares under the AfroCentric LTIP

AfroCentric Investment Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number 1988/000570/06)
JSE Code: ACT ISIN: ZAE000078416
(“the Company" or “AfroCentric”)



Dealings in securities by Directors of Afrocentric and a Director of a major subsidiary of AfroCentric relating to
vesting of shares under the AfroCentric Long Term Incentive Plan (“LTIP”)

In compliance with paragraphs 3.63 to 3.74 of the JSE Limited Listings Requirements, the Company
hereby discloses the following trades by Directors and a Director of a Major Subsidiary of AfroCentric
relating to the acceptance of Share Awards awarded in terms of the rules of the AfroCentric Long Term
Incentive Plan (“LTIP”) and are advised of the following information relating to the vesting of Share Awards
in respect of the first* and second** tranches (being 1/3rd of Share Awards after the expiry of the Retention
Period i.e. in years 3* (three) and 4** (four) after Award Date). The price per share, for purposes of
determining the market value, is the 30 day VWAP price per AfroCentric shares on 18 March 2022 being
481 cents per share:



 Name of director:                               Ahmed Banderker*
 Designation:                                    Chief Executive Officer of AfroCentric
 Date of transaction:                            18 March 2022
 Nature of transaction:                          Acceptance of Share Awards in terms of the Company’s
                                                 LTIP (first tranche)
 Class of security:                              Ordinary shares
 Number of securities:                           166 667
 Price per security:                             481 cents per share
 Value of transaction:                           R801 668.27
 Nature of interest:                             Direct Beneficial
 Clearance obtained:                             Yes
 Name of director:                               Hannes Boonzaaier**
 Designation:                                    Executive Director of AfroCentric
 Date of transaction:                            18 March 2022
 Nature of transaction:                          Acceptance of Share Awards in terms of the Company’s
                                                 LTIP (second tranche)
 Class of security:                              Ordinary shares
 Number of securities:                           133 334
 Price per security:                             481 cents per share
 Value of transaction:                           R641 336.54
 Nature of interest:                             Direct Beneficial
 Clearance obtained:                             Yes
 Name of director:                               Aklaaq Ahmed Mahmood**
 Designation:                                    Executive Director of Medscheme, a major subsidiary of
                                                 the Company
 Date of transaction:                            18 March 2022
 Nature of transaction:                          Acceptance of Share Awards in terms of the Company’s
                                                 LTIP (second tranche)
 Class of security:                    Ordinary shares
 Number of securities:                 100 000
 Price per security:                   481 cents per share
 Value of transaction:                 R481 000.00
 Nature of interest:                   Direct Beneficial
 Clearance obtained:                   Yes




Johannesburg
22 March 2022



JSE Sponsor to AfroCentric




Questco Corporate Advisory Proprietary Limited

Date: 22-03-2022 12:45:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.